The Board denied the claims for service connection for peripheral neuropathy of both feet and dismissed the TDIU claim as moot due to a previous grant.
The deciding factor: The evidence submitted was not new and relevant, thus readjudication was not warranted.
- Claimed conditions
- Peripheral neuropathy of the left foot, Peripheral neuropathy of the right foot
- How they argued it
- Reopened with new and material evidence
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- May 15, 2025
- Citation
- A25043913
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Granted
The Board granted an effective date of December 7, 2021, for the award of TDIU and DEA benefits.
- Granted
The Board granted service connection for a heart disability, MGUS, asymptomatic multiple myeloma, smoldering multiple myeloma, and peripheral neuropathy of the bilateral hands, forearms, lower legs, and feet based on toxic exposure risk activities during active service.
- Remanded (sent back)
The Board remands the claim for service connection for sarcoidosis as new and relevant evidence has been received since the previous denial.
- Remanded (sent back)
The Board remands the claim for service connection for tinnitus to correct a duty to assist error, as the Veteran's lay statements regarding onset and continuity of symptoms were not adequately considered in the previous decision.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.